about
Trial WatchNuclear factor of activated T cells - a transcription factor family as critical regulator in lung and colon cancerRole of TH17 cytokines in the control of colorectal cancerAssessment of sequence homology and immunologic cross-reactivity between tree shrew (Tupaia belangeri) and human IL-21.Common gamma chain cytokines in combinatorial immune strategies against cancerSystemic administration of attenuated Salmonella typhimurium in combination with interleukin-21 for cancer therapy.Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.IL-21 in cancer immunotherapy: At the right place at the right time.IL-21 gene polymorphism is associated with the prognosis of breast cancer in Chinese populations.
P2860
Q24618653-C7BB2799-A02B-4CE1-80B7-97E7B5A1BE24Q26824937-B9E1138E-46B6-487F-9614-378017F20373Q26860784-A05304BB-AFA7-4A2B-B8E8-FDB9E1961B86Q30401623-EF91AA88-3840-4569-B82D-2C8BA71C12B3Q36455872-59124038-E5BF-4EED-9DD1-56450BE716ADQ37560917-F92C408A-EF1C-436B-A015-3C110BB7D545Q40696087-E5D612A6-4256-49C0-9B69-15572E7F181BQ41977992-4597FB27-8E3B-4372-858A-0DE24D4509EEQ45888188-2CF5E77E-F752-4A46-B0EF-E4BCF6D5BF69
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Interleukin-21 in cancer immunotherapy: Friend or foe?
@en
type
label
Interleukin-21 in cancer immunotherapy: Friend or foe?
@en
prefLabel
Interleukin-21 in cancer immunotherapy: Friend or foe?
@en
P2093
P2860
P356
P1433
P1476
Interleukin-21 in cancer immunotherapy: Friend or foe?
@en
P2093
Francesco Pallone
Giovanni Monteleone
Thomas T Macdonald
P2860
P304
P356
10.4161/ONCI.19122
P577
2012-05-01T00:00:00Z